Effectiveness of Monovalent mRNA COVID-19 Vaccination Among Immunocompetent Adults During the Omicron Variant Period
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
MMWR. Morbidity and Mortality Weekly Report
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023
MMWR Morb. Mortal. Wkly. Rep. 2023 Apr 28;72(17)463-468, J DeCuir, D Surie, Y Zhu, M Gaglani, AA Ginde, DJ Douin, HK Talbot, JD Casey, NM Mohr, T McNeal, S Ghamande, KW Gibbs, DC Files, DN Hager, M Phan, ME Prekker, MN Gong, A Mohamed, NJ Johnson, JS Steingrub, ID Peltan, SM Brown, ET Martin, AS Monto, A Khan, WS Bender, A Duggal, JG Wilson, N Qadir, SY Chang, C Mallow, JH Kwon, MC Exline, AS Lauring, NI Shapiro, C Columbus, R Gottlieb, IA Vaughn, M Ramesh, LE Lamerato, B Safdar, N Halasa, JD Chappell, CG Grijalva, A Baughman, KN Womack, JP Rhoads, KW Hart, SA Swan, N Lewis, ML McMorrow, WH SelfFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.